BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35578828)

  • 1. A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors.
    Holloway K; Campbell C; Ali R; Huyer LD; Hart D; Haw J; Brennenstuhl S; Grundy Q
    Transfus Med; 2022 Oct; 32(5):351-365. PubMed ID: 35578828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
    Masser BM; Ferguson E; Thorpe R; Lawrence C; Davison TE; Hoad V; Gosbell IB
    Transfus Med; 2021 Jun; 31(3):176-185. PubMed ID: 33368777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 convalescent plasma donors: Unique motivations in unique times?
    Crowder LA; Steele WR; Goodhue E; Lasky B; Young PP
    Transfusion; 2023 Apr; 63(4):703-710. PubMed ID: 36866426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
    Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
    Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations and deterrents of blood donation among blood donors during the COVID-19 pandemic in Hong Kong.
    Siu JY; Chan EA; Li AS; Lee YM
    Health Expect; 2022 Dec; 25(6):3192-3201. PubMed ID: 36245309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors.
    Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M
    Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring predictors of Australian community members' blood donation intentions and blood donation-related behavior during the COVID-19 pandemic.
    Masser BM; Hyde MK; Ferguson E
    Transfusion; 2020 Dec; 60(12):2907-2917. PubMed ID: 32905630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening donors for COVID-19 convalescent plasma.
    Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
    Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor tolerability of convalescent plasma donation.
    He R; Lin H; Xie S; Lv Q; Kong Y; Li L; Xu H; Wang J; Li W; Fang P; Wu Y; Liu Z
    J Clin Apher; 2021 Jun; 36(3):429-436. PubMed ID: 33587767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of whole-blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin.
    Hyde MK; Masser BM; Coundouris SP
    Transfus Med; 2022 Apr; 32(2):95-114. PubMed ID: 35068004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivation, blood donor satisfaction and intention to return during the COVID-19 pandemic.
    Weidmann C; Derstroff M; Klüter H; Oesterer M; Müller-Steinhardt M
    Vox Sang; 2022 Apr; 117(4):488-494. PubMed ID: 34725833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
    Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries.
    Chandler T; Neumann-Böhme S; Sabat I; Barros PP; Brouwer W; van Exel J; Schreyögg J; Torbica A; Stargardt T
    Vox Sang; 2021 Nov; 116(10):1031-1041. PubMed ID: 33835509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these.
    Mahapatra S; Pati S
    Transfus Clin Biol; 2021 May; 28(2):175-179. PubMed ID: 33677086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia.
    Nurarifah N; Brahmantyo HP; Wardhani SO; Hermanto DH; Arsana PM
    Front Immunol; 2021; 12():633323. PubMed ID: 34790190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
    Fabricius MM; Dandachi D
    Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating imperfect policies to donate plasma: Survey on plasma donation and a pilot plasma donation program among men who have sex with men in Canada.
    Vesnaver E; Gibson E; Goldman M; Butler-Foster T; Hill NE; Lapierre D; MacDonagh R; Rubini KA; Miguel G; Rosser A; MacPherson P; Palumbo A; Randall T; Osbourne-Sorrell W; O'Brien SF; Otis J; Greaves M; Al-Bakri TB; Reid M; Labrecque M; Germain M; Orvis S; Clapperton AT; Devine D; Presseau J
    Transfusion; 2023 Jun; 63(6):1172-1183. PubMed ID: 37218408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation.
    Maheshwari A; Varshney M; Gupta K; Bajpai M
    Transfus Clin Biol; 2021 Aug; 28(3):254-257. PubMed ID: 33895379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.
    Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S
    Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.